|
Peg-Interferon α Clinical Trials
1 actively recruiting trial
Also known as: nucleo(s)tide analogue
Pipeline
Phase 4: 1
Top Sponsors
- First Affiliated Hospital of Wenzhou Medical University1
Indications
- Nonalcoholic Fatty Liver Disease1
- Liver Disease1
- Chronic Hepatitis b1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.